Impact of a clinical decision support system on identifying drug‐related problems and making recommendations to providers during community pharmacist‐led medication reviews in Ontario, Canada: A pilot study
Journal of Evaluation in Clinical Practice · 2025
DOI: 10.1111/jep.14123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Evaluation in Clinical Practice, 2025. Verfasst von Karen Riley und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hogan Pharmacy Partners LTD, Sarnia, Ontario, Canada. Hauptthemen laut MEDLINE: Decision Support Systems, Clinical, Community Pharmacy Services, Pharmacists, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Canadian Foundation of Pharmacy (CFP).
Abstract (Originalsprache)
Objective
To evaluate the impact of a clinical decision support system (CDSS) to identify drug‐related problems (DRPs) during community pharmacist medication reviews.
Design
Pilot 3‐phase (group), open‐label study. Setting and Participants Two community pharmacies in Sarnia, Ontario, with pharmacists providing medication reviews to patients. Study Procedures Five pharmacists participated in three phases (groups). During Phase 1, pharmacists conducted medication reviews in 25 adult patients using the usual approaches. In Phase 2, pharmacists were trained to use a CDSS to identify DRPs, and then conducted medication reviews using the tool in a different group of 25 adult patients. In Phase 3, pharmacists conducted medication reviews without the aid of the CDSS in 25 additional adult patients. Main Outcome Measures The primary outcome was recommendation to the primary care physician to alter pharmacotherapy based on medication review, assessed using mean number and frequency (yes/no) of recommendations by patient. Secondary outcomes included number of potential DRPs, actual DRPs, medication review duration time, pharmacist's perceptions of the CDSS and patient satisfaction with medication review.
Results
The mean number of recommendations to primary care physicians to alter pharmacotherapy per patient in Phases 1, 2 and 3 did not differ: 1.0 (SD = I.2) versus 1.5 (1.0) versus 1.5 (1.0), respectively; p = 0.223. The percentage of patients with a pharmacy recommendation sent to physicians across the phases, however, differed: 52% versus 80% versus 88%, respectively; p = 0.010, with more in Phases 2 and 3 compared to 1. There were more potential DRPs in group 2 compared to other groups. There were no differences in actual DRPs and medication review time. Pharmacists had positive attitudes about the CDSS. Patients were generally satisfied with their medication review.
Conclusions
This small pilot study provides some preliminary evidence for performance and feasibility of a CDSS to identify DRPs that pharmacists will act on. Future research is recommended to validate these findings in a larger sample.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hogan Pharmacy Partners LTD, Sarnia, Ontario, Canada.
- KD Riley Pharmacist Professional Corporation, Sarnia, Ontario, Canada.
ORCID-Profile: Karen Riley
Förderung
- Canadian Foundation of Pharmacy (CFP)
Zitieren
APA
Riley, K., Yap, K., Foley, G., Lambe, J., & Lund, S. (2025). Impact of a clinical decision support system on identifying drug‐related problems and making recommendations to providers during community pharmacist‐led medication reviews in Ontario, Canada: A pilot study. Journal of Evaluation in Clinical Practice. https://doi.org/10.1111/jep.14123
Vancouver
Riley K, Yap K, Foley G, Lambe J, Lund S. Impact of a clinical decision support system on identifying drug‐related problems and making recommendations to providers during community pharmacist‐led medication reviews in Ontario, Canada: A pilot study. Journal of Evaluation in Clinical Practice. 2025. doi:10.1111/jep.14123
BibTeX
@article{Riley2025,
author = {Riley, Karen and Yap, Katherine and Foley, Gaelan and Lambe, John and Lund, Sean},
title = {Impact of a clinical decision support system on identifying drug‐related problems and making recommendations to providers during community pharmacist‐led medication reviews in Ontario, Canada: A pilot study},
journal = {Journal of Evaluation in Clinical Practice},
year = {2025},
doi = {10.1111/jep.14123}
}
EUVIMED